Ypsomed opens new production hall in Schwerin and announces further expansion

Press Releases Ypsomed Group

Burgdorf – Today Ypsomed celebrates the opening of a new production hall at its German site in Schwerin. The expansion will enable the company to increase its production capacity to meet the growing global demand for high-quality medical technology products. CEO of Ypsomed, Simon Michel, also announced a further expansion of the plant in the coming years.

Topics:
Access & Expansion

Read more...

mylife Loop reaches important milestone toward US approval

Press Releases Ypsomed Group

Burgdorf – The CamAPS FX algorithm has received market authorisation from the United States Food and Drug Administration (FDA). Ypsomed congratulates its partner CamDiab on this achievement and looks forward to further expanding their global partnership. Currently, the mylife YpsoPump is undergoing review by the FDA as an interoperable insulin pump, paving the way for mylife Loop to enter the US market.

Topics:
Access & Expansion

Read more...

Ypsomed builds a conference and cultural centre in Solothurn

Press Releases Ypsomed Group

Burgdorf – Ypsomed will build a conference and cultural centre in Solothurn and make it available for public events. This was announced yesterday by Simon Michel, CEO of Ypsomed, at a celebratory event attended by numerous guests, including the Mayor of Solothurn, Stefanie Ingold. The "Ypsomed Forum" can be hired for events and offers space for 50 to 300 people. The forum is scheduled to open in mid-2026.

Topics:
Access & Expansion

Read more...

Ypsomed expands production facility in Schwerin

Press Releases Ypsomed Group

Burgdorf – Ypsomed (SIX: YPSN) is building a new production hall in Schwerin and creating 60 new jobs in the process. The company held the groundbreaking ceremony last Friday thus signaling the start of the construction for the 3300 square meters of additional production space, plus a further 1600 square meters for warehouse capacity and logistics. Digging work is scheduled to begin in June. The plant is expected to be operational following a construction phase of one year. The expansion will allow Ypsomed's site in Schwerin to produce more than 250 million infusion sets, pens and autoinjectors per year going forward.

Topics:
Access & Expansion

Read more...

Go-ahead for a new Ypsomed production facility in China

Press Releases Ypsomed Group

Burgdorf – On 25 April 2023, the groundbreaking ceremony for Ypsomed's (SIX: YPSN) new production facility took place in the Changzhou National Hi-tech District. In order to be able to efficiently serve the rapidly growing Chinese market for injection systems, Ypsomed is investing over CHF 35 million in the new manufacturing plant in a first phase. Production is expected to commence in the second half of 2024.

Topics:
Access & Expansion

Read more...